Total Payments
$430,511
2024 Payments
$86,647
Companies
23
Transactions
838
Medicare Patients
3,000
Medicare Billing
$281,050
Payment Breakdown by Category
Other$347,962 (80.8%)
Travel$47,735 (11.1%)
Consulting$19,413 (4.5%)
Food & Beverage$15,146 (3.5%)
Education$254.44 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $325,904 | 166 | 75.7% |
| Travel and Lodging | $47,735 | 248 | 11.1% |
| Honoraria | $22,059 | 12 | 5.1% |
| Consulting Fee | $19,413 | 9 | 4.5% |
| Food and Beverage | $15,146 | 390 | 3.5% |
| Education | $254.44 | 13 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $199,082 | 337 | $0 (2024) |
| ABBVIE INC. | $95,385 | 198 | $0 (2024) |
| Allergan, Inc. | $39,476 | 100 | $0 (2021) |
| Melinta Therapeutics, LLC | $36,488 | 65 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $33,353 | 59 | $0 (2024) |
| La Jolla Pharmaceutical Company | $13,520 | 23 | $0 (2024) |
| The Medicines Company | $12,230 | 30 | $0 (2017) |
| Novo Nordisk Inc | $197.56 | 6 | $0 (2024) |
| Shionogi Inc | $125.00 | 1 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $115.10 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $86,647 | 128 | Gilead Sciences, Inc. ($49,871) |
| 2023 | $82,723 | 165 | Gilead Sciences, Inc. ($32,907) |
| 2022 | $42,252 | 89 | Gilead Sciences, Inc. ($15,546) |
| 2021 | $27,414 | 47 | AbbVie Inc. ($15,938) |
| 2020 | $35,180 | 71 | AbbVie Inc. ($15,621) |
| 2019 | $46,616 | 86 | Gilead Sciences, Inc. ($26,788) |
| 2018 | $47,650 | 114 | Gilead Sciences, Inc. ($18,209) |
| 2017 | $62,030 | 138 | Gilead Sciences Inc ($32,338) |
All Payment Transactions
838 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: VIROLOGY | ||||||
| 12/11/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $281.25 | General |
| Category: ANTIFUNGALS | ||||||
| 12/05/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: COVID-19 | ||||||
| 11/27/2024 | ABBVIE INC. | MAVYRET (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: VIROLOGY | ||||||
| 11/25/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: COVID-19 | ||||||
| 11/24/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: VIROLOGY | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $540.00 | General |
| Category: COVID-19 | ||||||
| 11/20/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $94.31 | General |
| Category: COVID-19 | ||||||
| 11/20/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: COVID-19 | ||||||
| 11/19/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: VIROLOGY | ||||||
| 11/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.34 | General |
| 11/12/2024 | ABBVIE INC. | MAVYRET (Drug) | Travel and Lodging | In-kind items and services | $133.10 | General |
| Category: VIROLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $33.83 | General |
| Category: VIROLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | MAVYRET (Drug) | Travel and Lodging | In-kind items and services | $27.85 | General |
| Category: VIROLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | MAVYRET (Drug) | Travel and Lodging | In-kind items and services | $53.11 | General |
| Category: VIROLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $36.24 | General |
| Category: VIROLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | MAVYRET (Drug) | Travel and Lodging | In-kind items and services | $29.07 | General |
| Category: VIROLOGY | ||||||
| 11/07/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,170.00 | General |
| Category: HCV | ||||||
| 11/07/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: HCV | ||||||
| 11/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.93 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $92.96 | General |
| Category: HCV | ||||||
| 11/01/2024 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Honoraria | Cash or cash equivalent | $2,680.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $3.53 | General |
| 10/24/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: VIROLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | MAVYRET (Drug) | Travel and Lodging | In-kind items and services | $234.16 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 556 | 1,093 | $136,165 | $53,818 |
| 2022 | 17 | 770 | 1,360 | $172,875 | $66,388 |
| 2021 | 20 | 831 | 1,613 | $212,615 | $79,371 |
| 2020 | 19 | 843 | 1,672 | $228,715 | $81,472 |
Total Patients
3,000
Total Services
5,738
Medicare Billing
$281,050
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 121 | 456 | $68,400 | $27,459 | 40.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 144 | 181 | $36,200 | $17,861 | 49.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 24 | 25 | $5,000 | $1,875 | 37.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $4,200 | $1,874 | 44.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 35 | 42 | $3,780 | $1,610 | 42.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 70 | 122 | $7,380 | $1,263 | 17.1% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 67 | 117 | $4,200 | $741.78 | 17.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 21 | 36 | $2,700 | $472.32 | 17.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 18 | 35 | $1,925 | $333.20 | 17.3% |
| 83735 | Magnesium level | Office | 2023 | 15 | 21 | $840.00 | $137.97 | 16.4% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 14 | 22 | $880.00 | $124.52 | 14.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 13 | 22 | $660.00 | $68.42 | 10.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 139 | 479 | $71,850 | $26,179 | 36.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 138 | 161 | $32,200 | $16,587 | 51.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 46 | 47 | $14,100 | $7,197 | 51.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 89 | $20,025 | $7,067 | 35.3% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 20 | 24 | $4,800 | $3,365 | 70.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 37 | 50 | $4,500 | $1,492 | 33.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 86 | 138 | $8,280 | $1,438 | 17.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 79 | 107 | $4,280 | $821.87 | 19.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 22 | 45 | $3,375 | $595.04 | 17.6% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 38 | 42 | $2,520 | $531.70 | 21.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 19 | 29 | $1,595 | $277.77 | 17.4% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 27 | 31 | $1,085 | $196.54 | 18.1% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2022 | 33 | 40 | $1,200 | $168.52 | 14.0% |
About Dr. Fares Khater, MD
Dr. Fares Khater, MD is a Internal Medicine healthcare provider based in Whitesburg, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992732101.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fares Khater, MD has received a total of $430,511 in payments from pharmaceutical and medical device companies, with $86,647 received in 2024. These payments were reported across 838 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($325,904).
As a Medicare-enrolled provider, Khater has provided services to 3,000 Medicare beneficiaries, totaling 5,738 services with total Medicare billing of $281,050. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location Whitesburg, KY
- Active Since 06/26/2006
- Last Updated 01/04/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1992732101
Products in Payments
- Epclusa (Drug) $120,788
- MAVYRET (Drug) $60,810
- NUZYRA (Drug) $33,353
- Veklury (Drug) $23,477
- AVYCAZ (Drug) $22,998
- Mavyret (Drug) $19,695
- Kimyrsa (Drug) $18,523
- DALVANCE (Drug) $17,537
- TEFLARO (Drug) $7,469
- Vabomere (Drug) $6,961
- Rezzayo (Drug) $6,357
- ORBACTIV (Drug) $5,983
- XACDURO (Drug) $5,891
- Vosevi (Drug) $5,136
- Orbactiv (Drug) $4,534
- VABOMERE (Drug) $4,420
- XERAVA (Drug) $3,929
- GIAPREZA (Drug) $3,701
- MINOCIN IV (Drug) $1,826
- Fetroja (Drug) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Whitesburg
Dr. Byron Thomas, D.o, D.O
Internal Medicine — Payments: $2,643
Internal Medicine $2,643
William Collins, M.d, M.D
Internal Medicine — Payments: $2,154
Internal Medicine $2,154
Kevin Gooch, Md, MD
Internal Medicine — Payments: $1,815
Internal Medicine $1,815
April Hall-Slone, D.o, D.O
Internal Medicine — Payments: $1,737
Internal Medicine $1,737
Dr. Matthew Breeding, D.o, D.O
Internal Medicine — Payments: $1,593
Internal Medicine $1,593
Adnan Bhopalwala, Md, MD
Internal Medicine — Payments: $1,340
Internal Medicine $1,340